Market Closed -
Hong Kong S.E.
04:08:24 2024-06-06 am EDT
|
5-day change
|
1st Jan Change
|
26.55
HKD
|
+0.38%
|
|
-1.48%
|
-32.10%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
402,020
|
159,955
|
200,382
|
113,318
|
78,274
|
-
|
-
|
Enterprise Value (EV)
1 |
369,839
|
118,166
|
154,618
|
98,400
|
58,450
|
50,928
|
44,859
|
P/E ratio
|
-16.2
x
|
-143
x
|
525
x
|
52.3
x
|
32.4
x
|
25
x
|
19.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
20.7
x
|
5.21
x
|
4.29
x
|
2.12
x
|
1.26
x
|
1.09
x
|
0.94
x
|
EV / Revenue
|
19.1
x
|
3.85
x
|
3.31
x
|
1.84
x
|
0.94
x
|
0.71
x
|
0.54
x
|
EV / EBITDA
|
976
x
|
-90.7
x
|
877
x
|
106
x
|
33.6
x
|
18.5
x
|
11.8
x
|
EV / FCF
|
101
x
|
40.5
x
|
26.4
x
|
-
|
12.3
x
|
7.86
x
|
5.38
x
|
FCF Yield
|
0.99%
|
2.47%
|
3.79%
|
-
|
8.13%
|
12.7%
|
18.6%
|
Price to Book
|
7.1
x
|
3.89
x
|
4.37
x
|
2.25
x
|
1.48
x
|
1.37
x
|
1.25
x
|
Nbr of stocks (in thousands)
|
3,184,367
|
3,194,617
|
3,179,915
|
3,188,615
|
3,189,465
|
-
|
-
|
Reference price
2 |
126.2
|
50.07
|
63.01
|
35.54
|
24.54
|
24.54
|
24.54
|
Announcement Date
|
3/29/21
|
3/28/22
|
3/22/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
10,842
|
19,383
|
30,682
|
46,736
|
53,530
|
61,884
|
72,112
|
82,939
|
EBITDA
1 |
-
|
378.9
|
-1,303
|
176.3
|
928.2
|
1,738
|
2,752
|
3,816
|
EBIT
1 |
-
|
351.7
|
-1,366
|
35.6
|
894.4
|
1,519
|
2,567
|
3,779
|
Operating Margin
|
-
|
1.81%
|
-4.45%
|
0.08%
|
1.67%
|
2.45%
|
3.56%
|
4.56%
|
Earnings before Tax (EBT)
1 |
-
|
-17,072
|
-901.5
|
695.8
|
2,693
|
3,007
|
3,818
|
4,808
|
Net income
1 |
-971.8
|
-17,234
|
-1,074
|
380.1
|
2,142
|
2,419
|
3,154
|
4,027
|
Net margin
|
-8.96%
|
-88.92%
|
-3.5%
|
0.81%
|
4%
|
3.91%
|
4.37%
|
4.85%
|
EPS
2 |
-
|
-7.800
|
-0.3500
|
0.1200
|
0.6800
|
0.7585
|
0.9834
|
1.249
|
Free Cash Flow
1 |
-
|
3,662
|
2,921
|
5,865
|
-
|
4,750
|
6,481
|
8,345
|
FCF margin
|
-
|
18.89%
|
9.52%
|
12.55%
|
-
|
7.68%
|
8.99%
|
10.06%
|
FCF Conversion (EBITDA)
|
-
|
966.35%
|
-
|
3,327.11%
|
-
|
273.35%
|
235.5%
|
218.68%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
1,542.99%
|
-
|
196.4%
|
205.49%
|
207.25%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/25/20
|
3/29/21
|
3/28/22
|
3/22/23
|
3/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 Q2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
10,605
|
13,638
|
17,044
|
20,225
|
26,511
|
13,160
|
27,110
|
26,420
|
29,137
|
32,217
|
EBITDA
|
-
|
-
|
-771.1
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
597.4
|
-808.5
|
1,201
|
-185.6
|
-
|
943.9
|
-243.2
|
794
|
1,176
|
Operating Margin
|
-
|
4.38%
|
-4.74%
|
5.94%
|
-0.7%
|
-
|
3.48%
|
-0.92%
|
2.73%
|
3.65%
|
Earnings before Tax (EBT)
|
-
|
-
|
-556.2
|
377.3
|
318.5
|
-
|
1,831
|
862.1
|
1,562
|
2,023
|
Net income
|
-
|
-454.2
|
-618.4
|
223
|
157.1
|
-
|
1,561
|
580.5
|
1,076
|
1,030
|
Net margin
|
-
|
-3.33%
|
-3.63%
|
1.1%
|
0.59%
|
-
|
5.76%
|
2.2%
|
3.69%
|
3.2%
|
EPS
|
-
|
-
|
-
|
0.0700
|
0.0500
|
-
|
0.4900
|
0.1900
|
0.3400
|
0.3200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/29/21
|
8/24/21
|
3/28/22
|
8/23/22
|
3/22/23
|
8/16/23
|
8/16/23
|
3/20/24
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
32,181
|
41,789
|
45,764
|
14,918
|
19,824
|
27,346
|
33,414
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
3,662
|
2,921
|
5,865
|
-
|
4,750
|
6,481
|
8,345
|
ROE (net income / shareholders' equity)
|
-
|
3.86%
|
-2.71%
|
0.9%
|
4.55%
|
5.88%
|
6.81%
|
7.77%
|
ROA (Net income/ Total Assets)
|
-
|
2.85%
|
-2.33%
|
0.7%
|
3.41%
|
3.4%
|
4.21%
|
4.76%
|
Assets
1 |
-
|
-605,613
|
45,998
|
54,639
|
62,783
|
71,243
|
74,909
|
84,680
|
Book Value Per Share
2 |
-
|
17.80
|
12.90
|
14.40
|
15.80
|
16.60
|
18.00
|
19.70
|
Cash Flow per Share
2 |
-
|
1.680
|
1.110
|
1.880
|
1.460
|
1.570
|
1.920
|
2.180
|
Capex
1 |
-
|
37.6
|
502
|
40.2
|
-
|
186
|
202
|
209
|
Capex / Sales
|
-
|
0.19%
|
1.64%
|
0.09%
|
-
|
0.3%
|
0.28%
|
0.25%
|
Announcement Date
|
11/25/20
|
3/29/21
|
3/28/22
|
3/22/23
|
3/20/24
|
-
|
-
|
-
|
Last Close Price
24.54
CNY Average target price
39.9
CNY Spread / Average Target +62.58% Consensus |
1st Jan change
|
Capi.
|
---|
| -32.10% | 10.8B | | -38.95% | 13.75B | | -10.85% | 7.31B | | +10.79% | 6.19B | | -11.53% | 5.89B | | +73.65% | 4.79B | | -3.94% | 4.58B | | -8.36% | 3.75B | | -19.80% | 3.14B | | -13.87% | 2.82B |
Other Drug Retailers
|